Literature DB >> 17346029

Highly efficient synthesis of azabicyclo[x.y.0]alkane amino acids and congeners by means of Rh-catalyzed cyclohydrocarbonylation.

Wen-Hua Chiou1, Nobihiro Mizutani, Iwao Ojima.   

Abstract

A highly efficient method for the synthesis of 1-azabicyclo[x.y.0]alkane amino acid derivatives and their congeners by means of extremely regioselective cyclohydrocarbonylation (CHC) is described. The CHC reactions are catalyzed by Rh-BIPHEPHOS complex under mild conditions. These CHC reaction processes involve (i) an extremely linear-selective hydroformylation of the terminal alkene moiety of a dehydrodipeptide substrate, (ii) intramolecular condensation to form cyclic N-acyliminium key intermediate, and (iii) the second cyclization through intramolecular nucleophilic addition of a heteoatom nucleophile to the cyclic N-acyliminium moiety to afford the corresponding 1-azabicyclo[x.y.0] system. This consecutive double cyclization process proceeds with extremely high diastereoselectivity in most cases. This method has been successfully applied to the syntheses of 1-azabicyclo[4.4.0], -[5.4.0], and -[4.3.0] systems. The mechanisms of the reactions and the rationale for the observed extremely high diastereoselectivity are presented. This Rh-catalyzed CHC process would serve as a highly efficient and versatile method for the syntheses of a variety of conformationally restrained dipeptides, peptidomimetics, alkaloids, and other biologically active natural or unnatural products.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346029      PMCID: PMC2527597          DOI: 10.1021/jo061692y

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  8 in total

1.  New and efficient synthesis of azabicyclo[4.4.0]alkane amino acids by Rh-catalyzed cyclohydrocarbonylation.

Authors:  Nobuhiro Mizutani; Wen-Hua Chiou; Iwao Ojima
Journal:  Org Lett       Date:  2002-12-26       Impact factor: 6.005

2.  Synthetic studies on an antitumor antibiotic, bleomycin. XII. Preparation of an L-2,3-diaminopropionic acid derivative as a synthetic intermediate.

Authors:  M Otsuka; A Kittaka; T Iimori; H Yamashita; S Kobayashi; M Ohno
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-02       Impact factor: 1.645

3.  Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase.

Authors:  J A Robl; C Q Sun; J Stevenson; D E Ryono; L M Simpkins; M P Cimarusti; T Dejneka; W A Slusarchyk; S Chao; L Stratton; R N Misra; M S Bednarz; M M Asaad; H S Cheung; B E Abboa-Offei; P L Smith; P D Mathers; M Fox; T R Schaeffer; A A Seymour; N C Trippodo
Journal:  J Med Chem       Date:  1997-05-23       Impact factor: 7.446

Review 4.  Design, synthesis, and application of azabicyclo[X.Y.0]alkanone amino acids as constrained dipeptide surrogates and peptide mimics.

Authors:  Jérôme Cluzeau; William D Lubell
Journal:  Biopolymers       Date:  2005       Impact factor: 2.505

5.  Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.

Authors:  J Wagner; J Kallen; C Ehrhardt; J P Evenou; D Wagner
Journal:  J Med Chem       Date:  1998-09-10       Impact factor: 7.446

6.  Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.

Authors:  C A Fink; J E Carlson; P A McTaggart; Y Qiao; R Webb; R Chatelain; A Y Jeng; A J Trapani
Journal:  J Med Chem       Date:  1996-08-02       Impact factor: 7.446

7.  Oxazolopiperidin-2-ones as type II' beta-turn mimetics: synthesis and conformational analysis.

Authors:  M A Estiarte; M Rubiralta; A Diez; M Thormann; E Giralt
Journal:  J Org Chem       Date:  2000-10-20       Impact factor: 4.354

8.  Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.

Authors:  J A Robl; M P Cimarusti; L M Simpkins; B Brown; D E Ryono; J E Bird; M M Asaad; T R Schaeffer; N C Trippodo
Journal:  J Med Chem       Date:  1996-01-19       Impact factor: 7.446

  8 in total
  2 in total

1.  Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP.

Authors:  Mitchell Vamos; Kate Welsh; Darren Finlay; Pooi San Lee; Peter D Mace; Scott J Snipas; Monica L Gonzalez; Santhi Reddy Ganji; Robert J Ardecky; Stefan J Riedl; Guy S Salvesen; Kristiina Vuori; John C Reed; Nicholas D P Cosford
Journal:  ACS Chem Biol       Date:  2013-02-05       Impact factor: 5.100

2.  Metal-free [3 + 2 + 1]/[2 + 2 + 1] biscyclization: stereospecific construction with concomitant functionalization of indolizin-5(1H)-one.

Authors:  Tuan-Jie Li; Zhong-Qiu Liu; Hong-Mei Yin; Chang-Sheng Yao; Bo Jiang; Xiang-Shan Wang; Shu-Jiang Tu; Xiu-Ling Li; Guigen Li
Journal:  J Org Chem       Date:  2013-11-07       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.